Cefditoren

Cefditoren
Systematic (IUPAC) name
(7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((Z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Clinical data
Trade names Spectracef
AHFS/Drugs.com monograph
MedlinePlus a605003
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 104145-95-1 N
ATC code J01DD16
PubChem CID 9870843
ChemSpider 8046534 Y
UNII 81QS09V3YW Y
KEGG D07639 N
ChEBI CHEBI:59343 Y
Chemical data
Formula C19H18N6O5S3 
Mol. mass 506.58 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.

Cefditoren is also marketed under the name Meiact.[1]

Contents

Clinical use

Indications

Cefditoren is used to treat uncomplicated skin and skin structure infections, community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis (ABECB), pharyngitis, and tonsillitis.

Formulations

Cefditoren is available as 200 and 400 mg tablets. It can be formulated as the prodrug cefditoren pivoxil.

References

External links